LivaNova (LIVN) Competitors $41.98 -0.56 (-1.32%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$41.60 -0.38 (-0.90%) As of 07/18/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. PEN, STVN, GKOS, BLCO, IRTC, SLNO, TMDX, INSP, NVST, and PRCTShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. LivaNova vs. Its Competitors Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova (NASDAQ:LIVN) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends. Is LIVN or PEN more profitable? Penumbra has a net margin of 3.41% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova-17.41% 13.67% 6.68% Penumbra 3.41%11.14%8.40% Does the media favor LIVN or PEN? In the previous week, LivaNova and LivaNova both had 5 articles in the media. Penumbra's average media sentiment score of 1.40 beat LivaNova's score of 1.35 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, LIVN or PEN? LivaNova has higher revenue and earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B1.83$63.23M-$4.09-10.26Penumbra$1.19B7.46$14.01M$1.06217.08 Do institutionals & insiders hold more shares of LIVN or PEN? 97.6% of LivaNova shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.3% of LivaNova shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, LIVN or PEN? LivaNova has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Do analysts prefer LIVN or PEN? LivaNova currently has a consensus target price of $59.29, suggesting a potential upside of 41.22%. Penumbra has a consensus target price of $305.07, suggesting a potential upside of 32.58%. Given LivaNova's stronger consensus rating and higher possible upside, equities research analysts clearly believe LivaNova is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryPenumbra beats LivaNova on 8 of the 15 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.32B$6.72B$5.55B$9.40BDividend YieldN/A1.30%3.75%4.03%P/E Ratio-10.2625.1728.0119.82Price / Sales1.8361.61432.8198.20Price / Cash10.0320.3736.1658.27Price / Book1.734.608.125.65Net Income$63.23M$174.76M$3.25B$257.91M7 Day Performance-5.30%0.40%1.68%3.38%1 Month Performance-7.06%2.10%7.30%11.11%1 Year Performance-20.66%2.11%32.89%18.99% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.3381 of 5 stars$41.98-1.3%$59.29+41.2%-20.9%$2.32B$1.25B-10.262,900News CoveragePositive NewsPENPenumbra4.8176 of 5 stars$238.82+0.4%$305.07+27.7%+20.6%$9.25B$1.24B225.314,500Positive NewsSTVNStevanato Group1.1099 of 5 stars€25.55+1.3%N/A+14.8%€7.74B€1.12B50.105,521GKOSGlaukos4.3719 of 5 stars$104.43+0.6%$134.67+29.0%-17.6%$5.97B$404.52M-44.06780BLCOBausch + Lomb2.628 of 5 stars$13.67-1.5%$15.45+13.1%-18.0%$4.83B$4.83B-13.2713,500IRTCiRhythm Technologies1.1598 of 5 stars$138.91+2.2%$138.60-0.2%+38.3%$4.43B$591.84M-44.242,000News CoverageAnalyst ForecastSLNOSoleno Therapeutics4.1834 of 5 stars$82.76+1.5%$108.70+31.3%+88.0%$4.17BN/A-17.9130Positive NewsAnalyst RevisionTMDXTransMedics Group2.0756 of 5 stars$116.88+3.9%$127.33+8.9%-23.9%$3.95B$441.54M85.94210Analyst ForecastINSPInspire Medical Systems4.869 of 5 stars$130.17-0.1%$211.91+62.8%-8.1%$3.84B$802.80M59.981,246Positive NewsAnalyst ForecastNVSTEnvista3.5402 of 5 stars$20.05-0.8%$20.23+0.9%+17.9%$3.40B$2.51B-3.0712,300News CoverageAnalyst RevisionPRCTPROCEPT BioRobotics2.2264 of 5 stars$58.17+2.7%$87.50+50.4%-12.6%$3.22B$249.12M-34.22430News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives IRTC Alternatives SLNO Alternatives TMDX Alternatives INSP Alternatives NVST Alternatives PRCT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIVN Stock Alerts